Lista de obras - Patricia L Blount - Dominio Público Uruguay

A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma

artículo científico publicado en 2010

Application of Biomarkers in Cancer Risk Management: Evaluation from Stochastic Clonal Evolutionary and Dynamic System Optimization Points of View ⬇️

artículo científico publicado el 24 de febrero de 2011

Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus

artículo científico publicado en 2015

Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.

artículo científico publicado en 2013

Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort

artículo científico publicado en 2015

Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.

artículo científico publicado en 2005

Biomarkers in Barrett's esophagus

scientific article published on 01 April 2003

Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

artículo científico publicado en 2008

Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma

scientific article published on 05 May 2009

Chromosomal instability in Barrett's esophagus is related to telomere shortening.

artículo científico publicado en 2006

Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.

artículo científico publicado en 2006

Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study

artículo científico publicado en 2008

Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus

artículo científico publicado en 2007

Genetic clonal diversity predicts progression to esophageal adenocarcinoma

artículo científico publicado en 2006

Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation

scientific article published on 01 March 2006

High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus.

artículo científico publicado en 2015

Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort

artículo científico publicado en 2014

Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma

artículo científico publicado en 2014

Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus

artículo científico publicado en 2009

Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage

artículo científico publicado en 2014

Leukocyte telomere length predicts cancer risk in Barrett's esophagus.

artículo científico publicado en 2007

Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus

artículo científico publicado en 2007

Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.

artículo científico publicado en 2005

Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus

scientific article published on 20 July 2006

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma

artículo científico publicado en 2007

NSAIDs modulate clonal evolution in Barrett's esophagus.

artículo científico publicado en 2013

Neosquamous epithelium does not typically arise from Barrett's epithelium.

artículo científico publicado en 2006

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study

artículo científico publicado en 2005

Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study

artículo científico publicado en 2009

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

artículo científico publicado en 2002

Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett's esophagus

artículo científico publicado en 2015

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward

artículo científico publicado en 2006

Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention

artículo científico publicado en 2014

Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.

artículo científico publicado en 2012

Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

artículo científico publicado en 2003

Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression

artículo científico publicado en 2008

Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus

artículo científico publicado en 2013

The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma

artículo científico publicado en 2004

The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus

artículo científico publicado en 2013

Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae

artículo científico publicado en 2002

Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus

artículo científico publicado en 2012

p16 mutation spectrum in the premalignant condition Barrett's esophagus

artículo científico publicado en 2008

Lista de obras de Patricia L Blount

A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma

Application of Biomarkers in Cancer Risk Management: Evaluation from Stochastic Clonal Evolutionary and Dynamic System Optimization Points of View ⬇️

Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus

Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.

Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort

Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.

Biomarkers in Barrett's esophagus

Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma

Chromosomal instability in Barrett's esophagus is related to telomere shortening.

Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.

Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study

Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus

Genetic clonal diversity predicts progression to esophageal adenocarcinoma

Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation

High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus.

Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort

Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma

Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus

Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage

Leukocyte telomere length predicts cancer risk in Barrett's esophagus.

Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus

Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.

Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma

NSAIDs modulate clonal evolution in Barrett's esophagus.

Neosquamous epithelium does not typically arise from Barrett's epithelium.

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study

Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett's esophagus

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward

Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention

Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.

Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression

Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus

The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma

The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus

Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae

Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus

p16 mutation spectrum in the premalignant condition Barrett's esophagus